Endocrinologist Audio From Hot Topics in NASH: Real-World Practice Implications of NASH Trial Designs

Kenneth Cusi, MD, FACP, FACE, explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.

Kenneth Cusi, MD, FACP, FACE
Program Director Released: March 29, 2019

Kenneth Cusi, MD, FACP, FACE, and Stephen A. Harrison, MD, COL (Ret.), FAASLD, explain how to interpret endpoints used in NASH studies so you can evaluate emerging treatments

Kenneth Cusi, MD, FACP, FACE
Program Director Stephen A. Harrison, MD, COL (Ret.), FAASLD Released: March 26, 2019

Raymond E. Soccio, MD, PhD, summarizes the roles of weight loss and diabetes drugs in NASH

Raymond E. Soccio, MD, PhD Released: March 7, 2019

Philip N. Newsome, PhD, FRCPE, summarizes the roles of weight loss and diabetes drugs in NASH

Philip N. Newsome, PhD, FRCPE Released: March 6, 2019